Eagle Bay Advisors LLC Ascendis Pharma A/S Transaction History
Eagle Bay Advisors LLC
- $170 Million
- Q3 2024
A detailed history of Eagle Bay Advisors LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 23 shares of ASND stock, worth $2,985. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23
Previous 23
-0.0%
Holding current value
$2,985
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ASND
# of Institutions
243Shares Held
58.8MCall Options Held
250KPut Options Held
377K-
Ra Capital Management, L.P. Boston, MA9.71MShares$1.26 Billion20.22% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.13MShares$666 Million3.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.99MShares$648 Million11.21% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.41MShares$573 Million1.03% of portfolio
-
Janus Henderson Group PLC London, X04.19MShares$543 Million0.33% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.24B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...